Expression and Gene Regulation Network of Adenosine Receptor A2B in Lung Adenocarcinoma: A Potential Diagnostic and Prognostic Biomarker

Co-inhibition of CD73 and ADORA2B Improves Long-Term Cigarette Smoke Induced Lung Injury

(2021) Zhi Tian et al.   Frontiers in Physiology

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

(2020) J. Mazieres et al.   ANNALS OF ONCOLOGY

The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth

(2020) Siqi Chen et al.   Cancer Immunology Research

Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer

(2020) Alexander Drilon et al.   NEW ENGLAND JOURNAL OF MEDICINE

ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer

(2019) Yan Jiao et al.   OncoTargets and Therapy

Adenosine Receptor Profiling Reveals an Association between the Presence of Spare Receptors and Cardiovascular Disorders

(2019) Emmanuel Fenouillet et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism

(2018) Elizabeth A Vecchio et al.   BRITISH JOURNAL OF PHARMACOLOGY

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target

(2018) Marta Román et al.   Molecular Cancer

Author Correction: Comprehensive molecular profiling of lung adenocarcinoma

(2018)   NATURE

Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension

(2018) Tinne C. J. Mertens et al.   Frontiers in Physiology

HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis

(2017) Kemly Philip et al.   FASEB JOURNAL

Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial

(2017) Alice T Shaw et al.   LANCET ONCOLOGY

Systematic analysis of gene expression alterations and clinical outcomes of STAT3 in cancer

(2017) Xiangrong Cui et al.   Oncotarget

Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer

(2017) Shuanshuan Xie et al.   Oncotarget

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

(2017) Darshan S. Chandrashekar et al.   NEOPLASIA

Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in MiceHighlights

(2016) Roman Covarrubias et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Knockdown of ANXA1 suppresses the biological behavior of human NSCLC cells in vitro

(2016) YING FANG et al.   Molecular Medicine Reports

Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?

(2016) Pier Andrea Borea et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B

(2016) Xuehui Hong et al.   Oncotarget

Purinergic Signaling to Terminate TLR Responses in Macrophages

(2016) Kajal Hamidzadeh et al.   Frontiers in Immunology

Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer

(2016) Wei-Ching Chen et al.   PLoS One

Adenosine A2b receptor promotes progression of human oral cancer

(2015) Hiroki Kasama et al.   BMC CANCER

Cell death in cancer therapy of lung adenocarcinoma

(2015) Anna Zagryazhskaya et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer

(2015) MAIKO OKANO et al.   ONCOLOGY REPORTS

Oncogenomic portals for the visualization and analysis of genome-wide cancer data

(2015) Katarzyna Klonowska et al.   Oncotarget

Investigation of circulating antibodies to ANXA1 in breast cancer

(2014) Yile Huang et al.   TUMOR BIOLOGY

Adenosine A2B Receptor and Hyaluronan Modulate Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

(2013) Harry Karmouty-Quintana et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers

(2013) H. A. Yu et al.   CLINICAL CANCER RESEARCH

Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis

(2013) C. J. Desmet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression

(2012) S. A. Selamat et al.   GENOME RESEARCH

Identification of Genes Upregulated in ALK-Positive and EGFR/KRAS/ALK-Negative Lung Adenocarcinomas

(2011) H. Okayama et al.   CANCER RESEARCH

Pharmacological and therapeutic effects of A3 adenosine receptor agonists

(2011) Pnina Fishman et al.   DRUG DISCOVERY TODAY

Adenosine promotes alternative macrophage activation via A2A and A2B receptors

(2011) Balázs Csóka et al.   FASEB JOURNAL

Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification

(2011) Prudence A. Russell et al.   Journal of Thoracic Oncology

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

(2010) Lei Yu et al.   INTERNATIONAL JOURNAL OF CANCER

The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function

(2010) David Warde-Farley et al.   NUCLEIC ACIDS RESEARCH

Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival

(2008) Maria Teresa Landi et al.   PLoS One